Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda

NCT00339456 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

155

Enrollment

NIH

Sponsor class

Conditions

HIV

Interventions

DRUG: HAART

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)